BURBANK, Dec. 23, 2005 (PRIMEZONE) -- Imaging3, Inc. (OTCBB:IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, today announced that the company's shares have been approved for trading on the NASD's Over-the-Counter Bulletin Board market under the symbol IMGG.
"We are very excited to go forth under our new trading symbol, IMGG," stated Dean Janes, the Company's Chairman and CEO. "Current shareholders and potential new investors can use the symbol to obtain our current trading and financial information, as well as getting news about our company's developments and accomplishments. We are also very excited about our business. With our breakthrough real-time medical imaging technology and expanding healthcare market opportunity, we believe we have the perfect combination of characteristics to develop a rapidly growing company for our shareholders."
About Imaging3
Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company's website at www.imaging3.com
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.